These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 31122236)
21. Neuroprotective Properties of Ferulic Acid in Preclinical Models of Alzheimer's Disease: A Systematic Literature Review. Zhou S; Dong X Curr Med Chem; 2023; 30(24):2796-2811. PubMed ID: 36065925 [TBL] [Abstract][Full Text] [Related]
22. Berberine Derivatives with Different Pharmacological Activities via Structural Modifications. Xiao D; Liu Z; Zhang S; Zhou M; He F; Zou M; Peng J; Xie X; Liu Y; Peng D Mini Rev Med Chem; 2018; 18(17):1424-1441. PubMed ID: 28325147 [TBL] [Abstract][Full Text] [Related]
23. The neuroprotective effects of Berberine against amyloid β-protein-induced apoptosis in primary cultured hippocampal neurons via mitochondria-related caspase pathway. Liang Y; Huang M; Jiang X; Liu Q; Chang X; Guo Y Neurosci Lett; 2017 Aug; 655():46-53. PubMed ID: 28668383 [TBL] [Abstract][Full Text] [Related]
24. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. Shinjyo N; Parkinson J; Bell J; Katsuno T; Bligh A J Integr Med; 2020 Mar; 18(2):125-151. PubMed ID: 32005442 [TBL] [Abstract][Full Text] [Related]
25. Quercetin in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies. Zhang XW; Chen JY; Ouyang D; Lu JH Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941000 [TBL] [Abstract][Full Text] [Related]
26. Resveratrol in experimental Alzheimer's disease models: A systematic review of preclinical studies. Chen JY; Zhu Q; Zhang S; OuYang D; Lu JH Pharmacol Res; 2019 Dec; 150():104476. PubMed ID: 31605783 [TBL] [Abstract][Full Text] [Related]
27. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. Zhu F; Qian C BMC Neurosci; 2006 Dec; 7():78. PubMed ID: 17137520 [TBL] [Abstract][Full Text] [Related]
28. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms. Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868 [TBL] [Abstract][Full Text] [Related]
29. α-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer`s Disease. Ma K; McLaurin J Curr Alzheimer Res; 2017; 14(1):18-29. PubMed ID: 27539595 [TBL] [Abstract][Full Text] [Related]
30. The Role of Berberine in the Multi-Target Treatment of Senile Dementia. Huang M; Chen S; Liang Y; Guo Y Curr Top Med Chem; 2016; 16(8):867-73. PubMed ID: 26311424 [TBL] [Abstract][Full Text] [Related]
31. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600 [TBL] [Abstract][Full Text] [Related]
32. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways. Giuliani D; Bitto A; Galantucci M; Zaffe D; Ottani A; Irrera N; Neri L; Cavallini GM; Altavilla D; Botticelli AR; Squadrito F; Guarini S Neurobiol Aging; 2014 Mar; 35(3):537-47. PubMed ID: 24094579 [TBL] [Abstract][Full Text] [Related]
33. Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats. Saleh SR; Abady MM; Nofal M; Yassa NW; Abdel-Latif MS; Nounou MI; Ghareeb DA; Abdel-Monaem N Curr Rev Clin Exp Pharmacol; 2021; 16(2):139-154. PubMed ID: 32598269 [TBL] [Abstract][Full Text] [Related]
34. Ibuprofen and lipoic acid diamide as co-drug with neuroprotective activity: pharmacological properties and effects in beta-amyloid (1-40) infused Alzheimer's disease rat model. Di Stefano A; Sozio P; Cerasa LS; Iannitelli A; Cataldi A; Zara S; Giorgioni G; Nasuti C Int J Immunopathol Pharmacol; 2010; 23(2):589-99. PubMed ID: 20646354 [TBL] [Abstract][Full Text] [Related]
35. Protective effect of berberine, an isoquinoline alkaloid ameliorates ethanol-induced oxidative stress and memory dysfunction in rats. Patil S; Tawari S; Mundhada D; Nadeem S Pharmacol Biochem Behav; 2015 Sep; 136():13-20. PubMed ID: 26159088 [TBL] [Abstract][Full Text] [Related]
36. Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease. Jiang H; Wang X; Huang L; Luo Z; Su T; Ding K; Li X Bioorg Med Chem; 2011 Dec; 19(23):7228-35. PubMed ID: 22041172 [TBL] [Abstract][Full Text] [Related]
37. Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase. Zhang H; Zhao C; Cao G; Guo L; Zhang S; Liang Y; Qin C; Su P; Li H; Zhang W Neuropharmacology; 2017 Oct; 125():408-417. PubMed ID: 28822725 [TBL] [Abstract][Full Text] [Related]
38. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Kulkarni SK; Dhir A Phytother Res; 2010 Mar; 24(3):317-24. PubMed ID: 19998323 [TBL] [Abstract][Full Text] [Related]
39. The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer's disease therapy. Habtemariam S Nat Prod Commun; 2011 Aug; 6(8):1089-90. PubMed ID: 21922905 [TBL] [Abstract][Full Text] [Related]
40. Involvement of environmentally relevant toxic metal mixture in Alzheimer's disease pathway alteration and protective role of berberine: Bioinformatics analysis and toxicogenomic screening. Živančević K; Baralić K; Bozic D; Miljaković EA; Djordjevic AB; Ćurčić M; Bulat Z; Antonijević B; Bulat P; Đukić-Ćosić D Food Chem Toxicol; 2022 Mar; 161():112839. PubMed ID: 35085532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]